ENTITY
Sumitomo Pharma

Sumitomo Pharma (4506 JP)

108
Analysis
Health Care • Japan
Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.
more
•03 Jul 2018 10:16

Japan & Korea @Smartkarma: Sharp, Activist in Korea, Alpine AGM & Zozo

Sharp offering update: C pref conversion going through Mio Kato, CFA provides an update on the Sharp offering. Sharp Corp (6753 JP) cancelled its...

Logo
349 Views
Share
bearish•Sumitomo Pharma
•27 Jun 2018 20:51

Current Market Price Discounts Favourable Outcome from Latuda’s Upcoming Binary Event

We reiterate our “Underweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earningsNeither through recent launches, nor...

•20 Apr 2018 18:16

Japan Pharmaceuticals: The Week that Was…

Nippon Shinyaku Co Ltd (4516 JP) @ ÂĄ 8,480 (up ~18% week-to-date) vs. our TP ÂĄ 8,600. We recommend booking profit at current levels. Takeda...

•13 Apr 2018 17:33

Japan Pharmaceuticals: The Week that Was…

Takeda Pharmaceutical Co Ltd (4502 JP) @ ÂĄ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ÂĄ...

bullish•Takeda Pharmaceutical
•06 Apr 2018 13:44

Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas

Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...

x